A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers Read more about A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers
OCS Lung Expand Post-Approval Study - Expand Follow-Up Data Collection Read more about OCS Lung Expand Post-Approval Study - Expand Follow-Up Data Collection
Posterior Wall And Left Atrial Appendage Empiric Electrical Isolation for Non-Paroxysmal Atrial Fibrillation Read more about Posterior Wall And Left Atrial Appendage Empiric Electrical Isolation for Non-Paroxysmal Atrial Fibrillation
Impact of Earlier Postpartum Contact on Postpartum Visit Compliance and Maternal Wellbeing Read more about Impact of Earlier Postpartum Contact on Postpartum Visit Compliance and Maternal Wellbeing
Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy Read more about Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy
Comparison of Ventricular Tachycardia Ablation Strategies in Patients With Ischemic Cardiomyopathy Read more about Comparison of Ventricular Tachycardia Ablation Strategies in Patients With Ischemic Cardiomyopathy
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel Read more about A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA) Read more about Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)
2 Dose Neuraxial Morphine for Prevention of PDPH Read more about 2 Dose Neuraxial Morphine for Prevention of PDPH
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation Read more about A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation